US FDA approves GE HealthCare’s diagnostic drug for the treatment of heart disease
The US Food and Drug Administration has approved a GE HealthCare diagnostic drug for use in detecting coronary heart disease, the company said on Friday.
POPULAR POSTS
IEA warns ‘electricity era’ will come after fossil fuels peak
October 17, 2024
Easter Island fights global plastic waste vortex
October 17, 2024
Egypt opens more galleries at its antiquities museum
October 17, 2024
LIVE STREAM